HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.

Abstract
Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens.
AuthorsB B Rasmussen, B V Pedersen, S M Thorpe, J Hilkens, J Hilgers, C Rose
JournalCancer research (Cancer Res) Vol. 45 Issue 3 Pg. 1424-7 (Mar 1985) ISSN: 0008-5472 [Print] United States
PMID3971385 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antigens, Surface
  • Receptors, Estrogen
Topics
  • Antibodies, Monoclonal (immunology)
  • Antigens, Neoplasm (analysis)
  • Antigens, Surface (analysis)
  • Breast Neoplasms (immunology, mortality)
  • Female
  • Humans
  • Lymphatic Metastasis
  • Prognosis
  • Receptors, Estrogen (analysis)
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: